
Nova MD Review
Best for: lowest 3-month compounded pricing with an explicit microdose program
Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules. All four GLP-1 prices are posted publicly, alongside sermorelin, NAD+, glutathione, and enclomiphene. Compounded semaglutide runs as low as $125/month on the 3-month plan and tirzepatide $199/month, with $50 off the first tirzepatide order.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Nova MD is a solid telehealth option with balanced features and pricing.
Nova MD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $125/mo
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Nova MD
Each dimension is scored algorithmically from Nova MD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.2/10At $125/mo, Nova MD runs about 26% below the $169 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.7/10Nova MD offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-05).
Accessibility10%
6.1/10Nova MD's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.5/10Nova MD provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Nova MD review
Last checked 2026-06-05- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Nova MD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Nova MD's current pricing and active discounts before you decide.
What we like
- On-page pricing published for all four SKUs (semaglutide and tirzepatide, 1- and 3-month)
- $125/mo semaglutide and $199/mo tirzepatide 3-month plans rank among the cheapest in the market
- $50 off first tirzepatide order shown publicly
- Explicit microdose / low-dose program for both semaglutide and tirzepatide
- Broader menu (sermorelin, NAD+, glutathione, enclomiphene) for longevity alongside GLP-1
- FSA/HSA eligible and cancel-anytime billing with same-day doctor review
Watch-outs
- Legal entity name and state of incorporation not disclosed
- Compounding pharmacy not named — only 'accredited facilities'
- LegitScript certification not confirmed (only 'Licensed US Providers' claims)
- Per-state availability not listed
- Compounded only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic
- Lab work and ongoing monitoring aren't clearly addressed
- Patient count (1,241+) is an unverified marketing claim
Nova MD: a cut-rate compounding shop with a real microdose lane
Nova MD is a small, price-led telehealth platform built around one promise: some of the cheapest compounded semaglutide and tirzepatide you'll find anywhere, with every price posted right on the page. If your only goal is to start a GLP-1 for as little money as possible and you're comfortable buying a compounded formulation, Nova MD earns a look. At $125 a month for compounded semaglutide on the longer plan — well under the category median of $169 — it undercuts most of the better-known names. But the savings come with real trade-offs in transparency, and you should go in with eyes open.
How the pricing actually works
Nova MD runs two plan lengths for each drug: a monthly plan billed and shipped one month at a time, and a quarterly plan billed and shipped every three months. The quarterly plan is where the headline numbers come from. Compounded semaglutide drops to $125 a month on the three-month plan versus a higher rate billed monthly, and tirzepatide lands at a low-two-hundreds monthly equivalent on the quarter, with the first order discounted by fifty dollars. So the advertised price assumes you pre-pay for a full quarter up front — a meaningful chunk of money in one charge, even if the per-month math looks great.
One detail worth flagging: tirzepatide pricing scales with your dose. The lowest tiers carry the cheap quarterly rate, but the company's own product page states that the higher doses (roughly dose four and up) jump to a substantially higher monthly price. That's normal for compounded tirzepatide, but it means the number that pulled you in may not be the number you pay six months from now as you titrate up. Budget for the climb.
What's bundled in
- The plan price covers the medication, your provider consultation, and shipping — Nova MD advertises free overnight or expedited delivery
- Same-day doctor review and prescriptions, with cancel-anytime billing
- FSA/HSA eligible on at least some plans
- A non-refundable provider/consultation fee (a low two-figure amount) applies if you cancel after the doctor reviews you but before your order ships
The medications and how they're dispensed
Nova MD is compounded-only. There is no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic here — if you specifically want an FDA-approved branded pen, this isn't your provider. What you get instead is compounded semaglutide and compounded tirzepatide, shipped, in the company's words, 'directly from our partner pharmacy' at 'accredited facilities.' Nova MD also displays the standard, legally required disclaimer that the FDA does not review or approve compounded medications for safety or effectiveness. Take that seriously — it's the core trade-off of the whole category, not boilerplate.
The genuine differentiator: an explicit microdose program
Most compounding telehealth brands quietly bury low-dose options or don't mention them at all. Nova MD does the opposite — it markets an explicit microdose / low-dose program for both semaglutide and tirzepatide as a named product line. For people who tolerate GLP-1s poorly, who want to ease in slowly, or who are using these drugs for gentler metabolic or appetite goals rather than aggressive weight loss, a provider that openly supports microdosing is genuinely useful and surprisingly hard to find. That, more than the rock-bottom price, is the most distinctive thing about Nova MD.
The menu also runs broader than GLP-1s alone. Nova MD lists sermorelin, NAD+, glutathione, and enclomiphene, positioning itself as a small longevity-and-wellness shop rather than a pure weight-loss clinic. If you want one login for a GLP-1 plus a peptide or two, that one-stop convenience has appeal.
Where Nova MD falls short
This is where honesty matters. Nova MD is a young, thin operation, and its transparency gaps are the reason it doesn't rank higher. The company does not publicly disclose its legal entity name or state of incorporation. It never names the actual compounding pharmacy your medication ships from — only 'accredited facilities.' We could not confirm LegitScript certification; the site makes only generic 'U.S. licensed physicians' and 'U.S. pharmacies' claims. Per-state availability isn't listed, so you can't confirm Nova MD even serves your state without contacting them. Lab work and ongoing monitoring aren't clearly spelled out. And the '1,241+ patients served' figure is an unverified marketing claim. There are also soft signals of a very recent, small build — including a brand presentation that appears to be mid-rebrand between 'Nova MD' and 'Nova Health.'
Who should choose it — and who should skip it
- Choose Nova MD if: price is your top priority, you're comfortable with compounded medication, you can pre-pay a quarter up front, or you specifically want a structured microdose program
- Skip it if: you want a brand-name pen, you need a clearly named pharmacy and disclosed corporate entity, you want documented lab work and ongoing monitoring, or you need to confirm coverage in your state before committing
Trust and safety: medium confidence
On the plus side, there are no FDA warning letters on file for Nova MD, and the company doesn't hide the compounding disclaimer. But our confidence sits at medium, and the reason is the stack of unanswered questions above: an undisclosed legal entity, an unnamed pharmacy, no confirmed LegitScript status, and no published state list. None of that is proof of a problem — plenty of legitimate small telehealth shops are simply early and light on disclosures — but it does mean you're trusting more on faith than you would with a larger, fully transparent competitor. See our scoring methodology for how we weigh these signals.
Bottom line
Nova MD is one of the cheapest legitimate-looking ways to start compounded semaglutide or tirzepatide, and its open microdose program is a real, uncommon strength. It's a reasonable pick for a budget-focused, compound-comfortable patient who values low price and a gentle-start option over institutional polish. But the missing entity details, unnamed pharmacy, and unconfirmed certification keep it out of the top tier. Confirm it serves your state, read the cancellation fee terms, and remember the quarterly price assumes you pay for three months at once — then decide whether the savings are worth trading away some transparency.
Ready to start with Nova MD?
Starting at $125/month. See current pricing and start your free consultation.
Alternatives to Nova MD
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nova MD review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Nova MD?
Starting at $125/month. See current pricing and start your free consultation.